 | • レポートコード：MRC2-11QY04746 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は間質血管画分のグローバル市場について調査・分析したレポートです。種類別（SVF分離製品、酵素分離、非酵素分離、自動POCデバイス、SVF吸引精製製品、SVFトランスファー製品）市場規模、用途別（病院、専門クリニック、幹細胞バンク/研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別間質血管画分の競争状況、市場シェア ・世界の間質血管画分市場：種類別市場規模 2015年-2020年（SVF分離製品、酵素分離、非酵素分離、自動POCデバイス、SVF吸引精製製品、SVFトランスファー製品） ・世界の間質血管画分市場：種類別市場規模予測 2021年-2026年（SVF分離製品、酵素分離、非酵素分離、自動POCデバイス、SVF吸引精製製品、SVFトランスファー製品） ・世界の間質血管画分市場：用途別市場規模 2015年-2020年（病院、専門クリニック、幹細胞バンク/研究所、その他） ・世界の間質血管画分市場：用途別市場規模予測 2021年-2026年（病院、専門クリニック、幹細胞バンク/研究所、その他） ・北米の間質血管画分市場分析：米国、カナダ ・ヨーロッパの間質血管画分市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの間質血管画分市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の間質血管画分市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの間質血管画分市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Cytori Therapeutics、GE Healthcare、Ingeneron、Medikan International、Tissue Genesis、Genesis Biosystems、Human Med、IntelliCell BioSciences、LifeCell ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Stromal vascular fraction skin treatment is a type of stem cell therapy based on isolation of adipose tissue during liposuction or lipo-aspiration procedures of patient’s own body.
With increasing age, regenerative and repair properties of skin are less effective due to decrease in stem cell count, and therefore, stromal vascular fraction treatment contains stem cell provides a boost in repair and maintenance mechanism of the skin leaving smooth, healthy, radiant skin.
Market Analysis and Insights: Global Stromal Vascular Fraction Market
The global Stromal Vascular Fraction market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Stromal Vascular Fraction Scope and Market Size
Stromal Vascular Fraction market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Stromal Vascular Fraction market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Cytori Therapeutics
GE Healthcare
Ingeneron
Medikan International
Tissue Genesis
Genesis Biosystems
Human Med
IntelliCell BioSciences
LifeCell
Market segment by Type, the product can be split into
SVF Isolation Products
Enzymatic Isolation
Non-enzymatic Isolation
Automated POC Devices
SVF Aspirate Purification Products
SVF Transfer Products
Market segment by Application, split into
Hospitals
Specialty Clinics
Stem Cell Banks/Laboratories
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Stromal Vascular Fraction Revenue
1.4 Market by Type
1.4.1 Global Stromal Vascular Fraction Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 SVF Isolation Products
1.4.3 Enzymatic Isolation
1.4.4 Non-enzymatic Isolation
1.4.5 Automated POC Devices
1.4.6 SVF Aspirate Purification Products
1.4.7 SVF Transfer Products
1.5 Market by Application
1.5.1 Global Stromal Vascular Fraction Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.5.4 Stem Cell Banks/Laboratories
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Stromal Vascular Fraction Market Perspective (2015-2026)
2.2 Global Stromal Vascular Fraction Growth Trends by Regions
2.2.1 Stromal Vascular Fraction Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Stromal Vascular Fraction Historic Market Share by Regions (2015-2020)
2.2.3 Stromal Vascular Fraction Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Stromal Vascular Fraction Market Growth Strategy
2.3.6 Primary Interviews with Key Stromal Vascular Fraction Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Stromal Vascular Fraction Players by Market Size
3.1.1 Global Top Stromal Vascular Fraction Players by Revenue (2015-2020)
3.1.2 Global Stromal Vascular Fraction Revenue Market Share by Players (2015-2020)
3.1.3 Global Stromal Vascular Fraction Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Stromal Vascular Fraction Market Concentration Ratio
3.2.1 Global Stromal Vascular Fraction Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Stromal Vascular Fraction Revenue in 2019
3.3 Stromal Vascular Fraction Key Players Head office and Area Served
3.4 Key Players Stromal Vascular Fraction Product Solution and Service
3.5 Date of Enter into Stromal Vascular Fraction Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Stromal Vascular Fraction Historic Market Size by Type (2015-2020)
4.2 Global Stromal Vascular Fraction Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Stromal Vascular Fraction Market Size by Application (2015-2020)
5.2 Global Stromal Vascular Fraction Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Stromal Vascular Fraction Market Size (2015-2020)
6.2 Stromal Vascular Fraction Key Players in North America (2019-2020)
6.3 North America Stromal Vascular Fraction Market Size by Type (2015-2020)
6.4 North America Stromal Vascular Fraction Market Size by Application (2015-2020)
7 Europe
7.1 Europe Stromal Vascular Fraction Market Size (2015-2020)
7.2 Stromal Vascular Fraction Key Players in Europe (2019-2020)
7.3 Europe Stromal Vascular Fraction Market Size by Type (2015-2020)
7.4 Europe Stromal Vascular Fraction Market Size by Application (2015-2020)
8 China
8.1 China Stromal Vascular Fraction Market Size (2015-2020)
8.2 Stromal Vascular Fraction Key Players in China (2019-2020)
8.3 China Stromal Vascular Fraction Market Size by Type (2015-2020)
8.4 China Stromal Vascular Fraction Market Size by Application (2015-2020)
9 Japan
9.1 Japan Stromal Vascular Fraction Market Size (2015-2020)
9.2 Stromal Vascular Fraction Key Players in Japan (2019-2020)
9.3 Japan Stromal Vascular Fraction Market Size by Type (2015-2020)
9.4 Japan Stromal Vascular Fraction Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Stromal Vascular Fraction Market Size (2015-2020)
10.2 Stromal Vascular Fraction Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Stromal Vascular Fraction Market Size by Type (2015-2020)
10.4 Southeast Asia Stromal Vascular Fraction Market Size by Application (2015-2020)
11 India
11.1 India Stromal Vascular Fraction Market Size (2015-2020)
11.2 Stromal Vascular Fraction Key Players in India (2019-2020)
11.3 India Stromal Vascular Fraction Market Size by Type (2015-2020)
11.4 India Stromal Vascular Fraction Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Stromal Vascular Fraction Market Size (2015-2020)
12.2 Stromal Vascular Fraction Key Players in Central & South America (2019-2020)
12.3 Central & South America Stromal Vascular Fraction Market Size by Type (2015-2020)
12.4 Central & South America Stromal Vascular Fraction Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Cytori Therapeutics
13.1.1 Cytori Therapeutics Company Details
13.1.2 Cytori Therapeutics Business Overview
13.1.3 Cytori Therapeutics Stromal Vascular Fraction Introduction
13.1.4 Cytori Therapeutics Revenue in Stromal Vascular Fraction Business (2015-2020))
13.1.5 Cytori Therapeutics Recent Development
13.2 GE Healthcare
13.2.1 GE Healthcare Company Details
13.2.2 GE Healthcare Business Overview
13.2.3 GE Healthcare Stromal Vascular Fraction Introduction
13.2.4 GE Healthcare Revenue in Stromal Vascular Fraction Business (2015-2020)
13.2.5 GE Healthcare Recent Development
13.3 Ingeneron
13.3.1 Ingeneron Company Details
13.3.2 Ingeneron Business Overview
13.3.3 Ingeneron Stromal Vascular Fraction Introduction
13.3.4 Ingeneron Revenue in Stromal Vascular Fraction Business (2015-2020)
13.3.5 Ingeneron Recent Development
13.4 Medikan International
13.4.1 Medikan International Company Details
13.4.2 Medikan International Business Overview
13.4.3 Medikan International Stromal Vascular Fraction Introduction
13.4.4 Medikan International Revenue in Stromal Vascular Fraction Business (2015-2020)
13.4.5 Medikan International Recent Development
13.5 Tissue Genesis
13.5.1 Tissue Genesis Company Details
13.5.2 Tissue Genesis Business Overview
13.5.3 Tissue Genesis Stromal Vascular Fraction Introduction
13.5.4 Tissue Genesis Revenue in Stromal Vascular Fraction Business (2015-2020)
13.5.5 Tissue Genesis Recent Development
13.6 Genesis Biosystems
13.6.1 Genesis Biosystems Company Details
13.6.2 Genesis Biosystems Business Overview
13.6.3 Genesis Biosystems Stromal Vascular Fraction Introduction
13.6.4 Genesis Biosystems Revenue in Stromal Vascular Fraction Business (2015-2020)
13.6.5 Genesis Biosystems Recent Development
13.7 Human Med
13.7.1 Human Med Company Details
13.7.2 Human Med Business Overview
13.7.3 Human Med Stromal Vascular Fraction Introduction
13.7.4 Human Med Revenue in Stromal Vascular Fraction Business (2015-2020)
13.7.5 Human Med Recent Development
13.8 IntelliCell BioSciences
13.8.1 IntelliCell BioSciences Company Details
13.8.2 IntelliCell BioSciences Business Overview
13.8.3 IntelliCell BioSciences Stromal Vascular Fraction Introduction
13.8.4 IntelliCell BioSciences Revenue in Stromal Vascular Fraction Business (2015-2020)
13.8.5 IntelliCell BioSciences Recent Development
13.9 LifeCell
13.9.1 LifeCell Company Details
13.9.2 LifeCell Business Overview
13.9.3 LifeCell Stromal Vascular Fraction Introduction
13.9.4 LifeCell Revenue in Stromal Vascular Fraction Business (2015-2020)
13.9.5 LifeCell Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Stromal Vascular Fraction Key Market Segments
Table 2. Key Players Covered: Ranking by Stromal Vascular Fraction Revenue
Table 3. Ranking of Global Top Stromal Vascular Fraction Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Stromal Vascular Fraction Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of SVF Isolation Products
Table 6. Key Players of Enzymatic Isolation
Table 7. Key Players of Non-enzymatic Isolation
Table 8. Key Players of Automated POC Devices
Table 9. Key Players of SVF Aspirate Purification Products
Table 10. Key Players of SVF Transfer Products
Table 11. Global Stromal Vascular Fraction Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Stromal Vascular Fraction Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Stromal Vascular Fraction Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Stromal Vascular Fraction Market Share by Regions (2015-2020)
Table 15. Global Stromal Vascular Fraction Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Stromal Vascular Fraction Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Stromal Vascular Fraction Market Growth Strategy
Table 21. Main Points Interviewed from Key Stromal Vascular Fraction Players
Table 22. Global Stromal Vascular Fraction Revenue by Players (2015-2020) (Million US$)
Table 23. Global Stromal Vascular Fraction Market Share by Players (2015-2020)
Table 24. Global Top Stromal Vascular Fraction Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stromal Vascular Fraction as of 2019)
Table 25. Global Stromal Vascular Fraction by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Stromal Vascular Fraction Product Solution and Service
Table 28. Date of Enter into Stromal Vascular Fraction Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Stromal Vascular Fraction Market Size by Type (2015-2020) (Million US$)
Table 31. Global Stromal Vascular Fraction Market Size Share by Type (2015-2020)
Table 32. Global Stromal Vascular Fraction Revenue Market Share by Type (2021-2026)
Table 33. Global Stromal Vascular Fraction Market Size Share by Application (2015-2020)
Table 34. Global Stromal Vascular Fraction Market Size by Application (2015-2020) (Million US$)
Table 35. Global Stromal Vascular Fraction Market Size Share by Application (2021-2026)
Table 36. North America Key Players Stromal Vascular Fraction Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Stromal Vascular Fraction Market Share (2019-2020)
Table 38. North America Stromal Vascular Fraction Market Size by Type (2015-2020) (Million US$)
Table 39. North America Stromal Vascular Fraction Market Share by Type (2015-2020)
Table 40. North America Stromal Vascular Fraction Market Size by Application (2015-2020) (Million US$)
Table 41. North America Stromal Vascular Fraction Market Share by Application (2015-2020)
Table 42. Europe Key Players Stromal Vascular Fraction Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Stromal Vascular Fraction Market Share (2019-2020)
Table 44. Europe Stromal Vascular Fraction Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Stromal Vascular Fraction Market Share by Type (2015-2020)
Table 46. Europe Stromal Vascular Fraction Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Stromal Vascular Fraction Market Share by Application (2015-2020)
Table 48. China Key Players Stromal Vascular Fraction Revenue (2019-2020) (Million US$)
Table 49. China Key Players Stromal Vascular Fraction Market Share (2019-2020)
Table 50. China Stromal Vascular Fraction Market Size by Type (2015-2020) (Million US$)
Table 51. China Stromal Vascular Fraction Market Share by Type (2015-2020)
Table 52. China Stromal Vascular Fraction Market Size by Application (2015-2020) (Million US$)
Table 53. China Stromal Vascular Fraction Market Share by Application (2015-2020)
Table 54. Japan Key Players Stromal Vascular Fraction Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Stromal Vascular Fraction Market Share (2019-2020)
Table 56. Japan Stromal Vascular Fraction Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Stromal Vascular Fraction Market Share by Type (2015-2020)
Table 58. Japan Stromal Vascular Fraction Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Stromal Vascular Fraction Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Stromal Vascular Fraction Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Stromal Vascular Fraction Market Share (2019-2020)
Table 62. Southeast Asia Stromal Vascular Fraction Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Stromal Vascular Fraction Market Share by Type (2015-2020)
Table 64. Southeast Asia Stromal Vascular Fraction Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Stromal Vascular Fraction Market Share by Application (2015-2020)
Table 66. India Key Players Stromal Vascular Fraction Revenue (2019-2020) (Million US$)
Table 67. India Key Players Stromal Vascular Fraction Market Share (2019-2020)
Table 68. India Stromal Vascular Fraction Market Size by Type (2015-2020) (Million US$)
Table 69. India Stromal Vascular Fraction Market Share by Type (2015-2020)
Table 70. India Stromal Vascular Fraction Market Size by Application (2015-2020) (Million US$)
Table 71. India Stromal Vascular Fraction Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Stromal Vascular Fraction Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Stromal Vascular Fraction Market Share (2019-2020)
Table 74. Central & South America Stromal Vascular Fraction Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Stromal Vascular Fraction Market Share by Type (2015-2020)
Table 76. Central & South America Stromal Vascular Fraction Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Stromal Vascular Fraction Market Share by Application (2015-2020)
Table 78. Cytori Therapeutics Company Details
Table 79. Cytori Therapeutics Business Overview
Table 80. Cytori Therapeutics Product
Table 81. Cytori Therapeutics Revenue in Stromal Vascular Fraction Business (2015-2020) (Million US$)
Table 82. Cytori Therapeutics Recent Development
Table 83. GE Healthcare Company Details
Table 84. GE Healthcare Business Overview
Table 85. GE Healthcare Product
Table 86. GE Healthcare Revenue in Stromal Vascular Fraction Business (2015-2020) (Million US$)
Table 87. GE Healthcare Recent Development
Table 88. Ingeneron Company Details
Table 89. Ingeneron Business Overview
Table 90. Ingeneron Product
Table 91. Ingeneron Revenue in Stromal Vascular Fraction Business (2015-2020) (Million US$)
Table 92. Ingeneron Recent Development
Table 93. Medikan International Company Details
Table 94. Medikan International Business Overview
Table 95. Medikan International Product
Table 96. Medikan International Revenue in Stromal Vascular Fraction Business (2015-2020) (Million US$)
Table 97. Medikan International Recent Development
Table 98. Tissue Genesis Company Details
Table 99. Tissue Genesis Business Overview
Table 100. Tissue Genesis Product
Table 101. Tissue Genesis Revenue in Stromal Vascular Fraction Business (2015-2020) (Million US$)
Table 102. Tissue Genesis Recent Development
Table 103. Genesis Biosystems Company Details
Table 104. Genesis Biosystems Business Overview
Table 105. Genesis Biosystems Product
Table 106. Genesis Biosystems Revenue in Stromal Vascular Fraction Business (2015-2020) (Million US$)
Table 107. Genesis Biosystems Recent Development
Table 108. Human Med Company Details
Table 109. Human Med Business Overview
Table 110. Human Med Product
Table 111. Human Med Revenue in Stromal Vascular Fraction Business (2015-2020) (Million US$)
Table 112. Human Med Recent Development
Table 113. IntelliCell BioSciences Business Overview
Table 114. IntelliCell BioSciences Product
Table 115. IntelliCell BioSciences Company Details
Table 116. IntelliCell BioSciences Revenue in Stromal Vascular Fraction Business (2015-2020) (Million US$)
Table 117. IntelliCell BioSciences Recent Development
Table 118. LifeCell Company Details
Table 119. LifeCell Business Overview
Table 120. LifeCell Product
Table 121. LifeCell Revenue in Stromal Vascular Fraction Business (2015-2020) (Million US$)
Table 122. LifeCell Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stromal Vascular Fraction Market Share by Type: 2020 VS 2026
Figure 2. SVF Isolation Products Features
Figure 3. Enzymatic Isolation Features
Figure 4. Non-enzymatic Isolation Features
Figure 5. Automated POC Devices Features
Figure 6. SVF Aspirate Purification Products Features
Figure 7. SVF Transfer Products Features
Figure 8. Global Stromal Vascular Fraction Market Share by Application: 2020 VS 2026
Figure 9. Hospitals Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Stem Cell Banks/Laboratories Case Studies
Figure 12. Others Case Studies
Figure 13. Stromal Vascular Fraction Report Years Considered
Figure 14. Global Stromal Vascular Fraction Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Stromal Vascular Fraction Market Share by Regions: 2020 VS 2026
Figure 16. Global Stromal Vascular Fraction Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Stromal Vascular Fraction Market Share by Players in 2019
Figure 19. Global Top Stromal Vascular Fraction Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stromal Vascular Fraction as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Stromal Vascular Fraction Revenue in 2019
Figure 21. North America Stromal Vascular Fraction Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Stromal Vascular Fraction Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Stromal Vascular Fraction Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Stromal Vascular Fraction Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Stromal Vascular Fraction Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Stromal Vascular Fraction Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Stromal Vascular Fraction Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
血漿分画の世界市場（～2026年） Blood plasma fractionation refers to the general processes of separating the various components of blood plasma, which in turn is a component of blood obtained through blood fractionation. Increasing awareness about the disease and increasing disposable income are expected to boost the growth of the…- 消化管間質腫瘍（GIST）の世界市場（～2026年） Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract. Treatment of gastrointestinal stromal tumor is multidisciplinary, entailing the involvement of medical oncologists, surgeons, radiologist, as well as path…
- 消化管間質腫瘍（GIST）治療の世界市場（～2026年） A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine. Market Analysis and Insights: Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market The global Gastrointestinal Stromal Tumors (GISTs) …
- 性腺性腺間質腫瘍治療の世界市場（～2026年） The sex cord-gonadal stromal tumor is a rare type of cancer derived from the stromal component of the ovary and testis. This tumor comprises granulosa, thecal cells, and fibrocytes. Market Analysis and Insights: Global Sex Cord Gonadal Stromal Tumor Treatment Market The global Sex Cord Gonadal Strom…
- 性腺性腺間質腫瘍の世界市場（～2026年） The sex cord-gonadal stromal tumor is a rare type of cancer derived from the stromal component of the ovary and testis. This tumor comprises granulosa, thecal cells, and fibrocytes. Sex cord-gonadal stromal tumors are mostly of seven types, namely, granulosa cell tumor, Sertoli cell tumor, thecoma, …